JUNGHEINRICH AG O.N.VZO/ DE0006219934 /
08/10/2024 17:35:18 | Var. -0.860 | Volume | Denaro08/10/2024 | Lettera17:41:51 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
25.840EUR | -3.22% | 72,010 Fatturato: 1.87 mill. |
-Quantità in denaro: - | -Quantità in lettera: - | 1.28 bill.EUR | 2.81% | 9.14 |
Newsfile Corp
23:41
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ex...
Newsfile Corp
23:29
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Do...
Newsfile Corp
23:29
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Al...
Newsfile Corp
23:24
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ne...
Newsfile Corp
23:15
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages STMicroelectronics N.V. Investors to Secure Counsel Befo...
Newsfile Corp
23:00
VIDEO - CEO Clips - CMI Mortgage Investments: Specialized Private Lending Solutions for Canadian Rea...
Newsfile Corp
22:50
Une représentante du Jennifer Landa Breast Cancer Visiting Lectureship ferme les marchés
Newsfile Corp
22:01
Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common ...
Newsfile Corp
21:17
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of NANO Nuclea...
Newsfile Corp
21:13
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna
Newsfile Corp
20:48
Vici Health Sciences Announces Launch of Phase I, Phase II, and Phase III Clinical Supplies Manufact...